Closed consultation

MHRA business engagement assessment on introduction of tell-and-do variations for a specific subset of parallel import licences

From:
Medicines and Healthcare products Regulatory Agency
Published
4 September 2013
Last updated
15 October 2013 — See all updates

We are analysing your feedback

Visit this page again soon to download the outcome to this public feedback.

Summary

The MHRA is seeking views on the proposal on the introduction of tell-and-do variations for a specific subset of parallel import licences.

This consultation ran from
to

Consultation description

The MHRA is seeking views on the proposal on the introduction of tell-and-do variations for a specific subset of parallel import licenses, captured in a new Business Engagement Assessment, which is part of the ongoing cross-government Accountability for Regulator Impact (ARI) project.

Businesses and representative organisations are invited to comment on any aspect of the published draft Assessment. Responses should be sent to regulator.impact@mhra.gsi.gov.uk stating the name of the proposal in the subject line. Responses will be published on the www.gov.uk website unless individual respondents ask us not to do so.

The deadline for comments is 1 Novemeber 2013 and final versions of the assessments will be published shortly thereafter.

Documents

MHRA business engagement assessment on introduction of tell-and-do variations for a specific subset of parallel import licences

Unnumbered act paper

PDF, 39.3 KB, 2 pages

Order a copy

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
Published 4 September 2013
Last updated 15 October 2013 + show all updates

  1. Updated document added.

  2. First published.

Related content